📰 Executive Albert Bourla News
Page 4 - Executive Albert Bourla News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Executive Albert Bourla. Real-time updates on events, politics, business and more.
February 9, 2022
NEW YORK, Feb 9, 2022 (BSS/AFP) - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and
February 9, 2022
NEW YORK - Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation.
February 8, 2022
Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
February 8, 2022
New York, United States Feb 8-Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more Kenya breaking news | Kenya news today |
February 8, 2022
The pharmaceutical giant, which with German company BioNTech won approval for the first vaccine to counter the deadly virus, saw annual revenues nearly double to $81.3 billion, with $36.8 billion from the COVID-19 vaccine.
February 8, 2022
NEW YORK, Feb 8 — Pfizer said today it expects US$32 billion (RM152 billion) in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to US$22 billion. The pharmaceutical giant, which with German company BioNTech won approval for the first vaccine to counter...
February 8, 2022
Pfizer said Tuesday it expects US$32bn in revenue from COVID-19 vaccines in 2022 as it reported annual profits had more than doubled to US$22bn.
February 8, 2022
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of…
February 8, 2022
Pfizer also expects $22 billion in sales of Paxlovid, the company's pill for COVID-19, in 2022.